The US$205 analyst price target for BDX is 37% less than our estimate of fair value In this article we are going to estimate the intrinsic value of Becton, Dickinson and Company (NYSE:BDX) by taking ...

On December 17, RBC Capital raised its price target on Becton, Dickinson and Company (NYSE:BDX) to $210 from $202 and kept a ...

(NASDAQ:NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the ...

The top 10 PharmTech videos of the year cover advanced therapies, high-concentration biologics, major mergers and ...

Over the past year, the application of generative AI (genAI) in the Medical Instruments industry has moved from experimental to operational, transforming diagnostics, patient monitoring and ...

Residents immediately informed the fire department after noticing the incident. However, before fire tenders could reach the ...

Between exiting the Smiths remediation process, leveraging new product introductions (and overhead leverage), and ...

The ProShares S&P 500 Dividend Aristocrat ETF (NOBL) underperformed SPY in 2025, gaining 7.2% versus SPY's 18.42%.

The surgical site infection control market is positioned for stable growth as healthcare systems continue to prioritize ...

The article 🌱 Patch AM: Why Westfield’s beloved 16 Prospect suddenly closed after 20-plus years appeared first on Westfield ...

The global pain management therapy market size was US$ 3.5 billion in 2021. The global pain management therapy market is forecast to grow to US$ 7.6 billion by 2030 by growing at a compound annual ...

A special master found this month that Heninger Garrison Davis and two of its partners, Lew Garrison and Bill Bross, and ...